Vaxxinity Banner Image


  • Ticker VAXX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Vaxxinity Logo Image
  • 51-200 Employees
  • Based in Cape Canaveral, Florida
Vaxxinity is a U.S.-based global biotechnology company pioneering a new class of medicines to democratize health. Headquartered in Dallas, TX, with operations in the United States, Latin America, Europe and Asia, the company’s proprietary technology platform has enabled the innovation of synthetic peptide vaccines designed to prevent or treat infectious diseases, including COVID-19, andMore chronic diseases, including Alzheimer's, Parkinson’s, migraine, and hypercholesterolemia.. Vaxxinity has optimized its pipeline to achieve a potentially historic, global impact on human health. The key to the platform is the proprietary library of UBITh peptides, which are immunosilent, avoiding inflammation, and when linked to custom-designed target antigens, can elicit highly specific antibodies.

Most Recent Annual Report

MOST RECENT 2023 Annual Report and Form 10K

Older/Archived Annual Reports

Vaxxinity Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!